Cargando…

Recent advances in the diagnosis and management of pre-eclampsia

Pre-eclampsia is a leading cause of maternal mortality, responsible annually for over 60,000 maternal deaths around the globe. Pre-eclampsia is a multisystem disease featuring hypertension, proteinuria, and renal, hepatic, and neurological involvement. Diagnosis is often elusive, as clinical present...

Descripción completa

Detalles Bibliográficos
Autores principales: Duhig, Kate, Vandermolen, Brooke, Shennan, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832913/
https://www.ncbi.nlm.nih.gov/pubmed/29560262
http://dx.doi.org/10.12688/f1000research.12249.1
_version_ 1783303387855454208
author Duhig, Kate
Vandermolen, Brooke
Shennan, Andrew
author_facet Duhig, Kate
Vandermolen, Brooke
Shennan, Andrew
author_sort Duhig, Kate
collection PubMed
description Pre-eclampsia is a leading cause of maternal mortality, responsible annually for over 60,000 maternal deaths around the globe. Pre-eclampsia is a multisystem disease featuring hypertension, proteinuria, and renal, hepatic, and neurological involvement. Diagnosis is often elusive, as clinical presentation is highly variable. Even those with severe disease can remain asymptomatic. Angiogenic factors are emerging as having a role in the diagnosis of pre-eclampsia and in prognostication of established disease. In this article, we summarize new developments and focus on angiogenic biomarkers for prediction of disease onset. We also discuss recent advances in management strategies for patients with hypertensive disorders of pregnancy.
format Online
Article
Text
id pubmed-5832913
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-58329132018-03-19 Recent advances in the diagnosis and management of pre-eclampsia Duhig, Kate Vandermolen, Brooke Shennan, Andrew F1000Res Review Pre-eclampsia is a leading cause of maternal mortality, responsible annually for over 60,000 maternal deaths around the globe. Pre-eclampsia is a multisystem disease featuring hypertension, proteinuria, and renal, hepatic, and neurological involvement. Diagnosis is often elusive, as clinical presentation is highly variable. Even those with severe disease can remain asymptomatic. Angiogenic factors are emerging as having a role in the diagnosis of pre-eclampsia and in prognostication of established disease. In this article, we summarize new developments and focus on angiogenic biomarkers for prediction of disease onset. We also discuss recent advances in management strategies for patients with hypertensive disorders of pregnancy. F1000 Research Limited 2018-02-28 /pmc/articles/PMC5832913/ /pubmed/29560262 http://dx.doi.org/10.12688/f1000research.12249.1 Text en Copyright: © 2018 Duhig K et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Duhig, Kate
Vandermolen, Brooke
Shennan, Andrew
Recent advances in the diagnosis and management of pre-eclampsia
title Recent advances in the diagnosis and management of pre-eclampsia
title_full Recent advances in the diagnosis and management of pre-eclampsia
title_fullStr Recent advances in the diagnosis and management of pre-eclampsia
title_full_unstemmed Recent advances in the diagnosis and management of pre-eclampsia
title_short Recent advances in the diagnosis and management of pre-eclampsia
title_sort recent advances in the diagnosis and management of pre-eclampsia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832913/
https://www.ncbi.nlm.nih.gov/pubmed/29560262
http://dx.doi.org/10.12688/f1000research.12249.1
work_keys_str_mv AT duhigkate recentadvancesinthediagnosisandmanagementofpreeclampsia
AT vandermolenbrooke recentadvancesinthediagnosisandmanagementofpreeclampsia
AT shennanandrew recentadvancesinthediagnosisandmanagementofpreeclampsia